For more information about healthcare performance, visit Abbott Diagnostics.
From a diagnostic perspective, the complexities of chronic HBV infection are challenging existing diagnostics with the need to stage chronic infection, identify occult cases, and detect mutations. There’s growing need in the monitoring of immunosuppressed patients with ultra-sensitive diagnostic tools that can identify HBV reactivation. Therapy monitoring for current and new antivirals utilizes both serological and molecular assays as well as exploring novel antigen and nucleic acid markers.
Join Patricia Slev as she discusses current testing algorithms used and updates the audience on the latest Hepatitis B virus guidelines.
What you will learn
Advances in viral hepatitis B testing
Recent changes in diagnostic guidelines for cases of reactivation
The new tools for diagnosing and managing viral hepatitis B infections
Patricia Slev, PhD, DABCC
Section Chief: Immunology Division
Medical Director: Serologic Hepatitis and Retrovirus Laboratory
Medical Director: Immunology Core Laboratory
Salt Lake City, UT
*Please ensure you have the most recent version of your browser to avoid a technical error.